StonvexLoading…
StonvexStonvexStonvexCore line items from INVA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $411.33M | $358.71M | $310.46M | $331.34M |
Operating Income | $163.75M | $166.87M | $113.89M | $286.95M |
Net Income | $271.17M | $23.39M | $179.72M | $220.26M |
EPS (Diluted) | $3.30 | $0.36 | $2.20 | $2.37 |
Total Assets | $1.64B | $1.30B | $1.24B | $1.23B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $550.94M | $304.96M | $193.51M | $291.05M |
Free Cash Flow OCF − CapEx | $195.80M | $188.42M | $140.65M | $201.66M |
Shares Outstanding | 74.64M | 62.66M | 63.31M | 69.19M |